Literature DB >> 19523753

A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy.

Robert Laforce1, Paul N Valdmanis, Nicolas Dupré, Guy A Rouleau, Alexis F Turgeon, Martin Savard.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive disorder characterized by gastrointestinal, extraocular muscle, peripheral nerve, and cerebral white matter involvement. Mutations in the nuclear gene TYMP encoding for thymidine phosphorylase (TP) cause loss of TP activity, systemic accumulation of its substrates in plasma and tissues, as well as alterations in mitochondrial DNA including deletions, depletion, and somatic point mutations. To date, more than 30 mutations have been reported in diverse ethnic populations. We present herein the clinical, neuroimaging, neuromuscular, and molecular findings of the first French Canadian patient with MNGIE caused by a novel homozygous invariant splicing site (IVS5 +1 G>A) mutation of the TYMP gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523753     DOI: 10.1016/j.clineuro.2009.05.005

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

Review 1.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

2.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation.

Authors:  Zeren Bariş; Tuba Eminoğlu; Buket Dalgiç; Leyla Tümer; Alev Hasanoğlu
Journal:  Eur J Pediatr       Date:  2010-06-29       Impact factor: 3.183

3.  Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.

Authors:  Jaap A Bakker; Patrick Schlesser; Hubert J M Smeets; Baudouin Francois; Jörgen Bierau
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

4.  Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Parham Habibzadeh; Mohammad Silawi; Hassan Dastsooz; Shima Bahramjahan; Shahrokh Ezzatzadegan Jahromi; Vahid Reza Ostovan; Majid Yavarian; Mohammad Mofatteh; Mohammad Ali Faghihi
Journal:  BMC Gastroenterol       Date:  2020-05-08       Impact factor: 3.067

Review 5.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

6.  Clinical spectrum of early onset "Mediterranean" (homozygous p.P131L mutation) mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Sema Kalkan Uçar; Havva Yazıcı; Ebru Canda; Esra Er; Fatma Derya Bulut; Cenk Eraslan; Hüseyin Onay; Bridget Elizabeth Bax; Mahmut Çoker
Journal:  JIMD Rep       Date:  2022-07-10

7.  Mitochondrial neurogastrointestinal encephalomyopathy in a Pakistani female: a case report.

Authors:  Zaraq Rashid Khan; Alvina Karam; Mian Ayaz Ul Haq; Aleena Aman; Ahmad Sharjeel Karam
Journal:  J Med Case Rep       Date:  2022-10-03

8.  Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.

Authors:  Bridget E Bax
Journal:  J Transl Genet Genom       Date:  2020-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.